A new market study, titled “Global Auto-Injectors Market Research Report 2018”, has been featured on WiseGuyReports.
This report studies the global Auto-Injectors market status and forecast, categorizes the global Auto-Injectors market size (value & volume) by key players, type, application, and region. This report focuses on the top players in North America, Europe, Asia-Pacific, South America, and Middle East & Africa.
Auto-injector is a medical device designed to deliver a dose of a particular drug.
Most auto-injectors are spring-loaded syringes. By design, auto-injectors are easy to use and are intended for self-administration by patients, or administration by untrained personnel. The site of injection depends on the drug loaded, but it typically is administered into the thigh or the buttocks.
Auto-Injectors are expected to present vast opportunities to investors due to high demand in biologics development. Overall revenues from the pre-filled syringes segment is expected to grow during the forecast period due to the rising need for targeted and sustained drug delivery.
The global average price of Auto-Injectors is in the increasing trend from 2013-2016, Auto-injectors manufacturers are introducing generic versions in order to reduce the overall cost of the device. In order to better serve anaphylaxis patients with epinephrine at an affordable cost, Mylan N.V. has implemented the decision of introducing the generic version of Epipen at half the price.
The classification of Auto-Injectors includes reusable Auto-Injectors and disposable Auto-Injectors, and the proportion of disposable Auto-Injectors in 2017 is about 62.7%, and the proportion is in increasing trend from 2013 to 2017.
Auto-injectors are pen like devices used to deliver a fixed dose of drug to patients and are intended for self-administration. Auto-injectors are gradually becoming the gold-standard in the treatment of various indications like anaphylaxis, multiple sclerosis, rheumatoid arthritis and others. The most proportion of Auto-Injectors is used for Anaphylaxis, and the proportion in 2017 is 56.9%.
North America is the largest consumption place, with a consumption market share nearly 59.5% in 2017. Following North America, Europe is the second largest consumption place with the consumption market share of 20%. China is also an important sales region.
Market competition is not intense. Mylan, BD, Johnson & Johnson, Amgen Inc., etc. are the leaders of the industry, and they hold key technologies and patents, with high-end customers; have been formed in the monopoly position in the industry.
The global Auto-Injectors market is valued at 1660 million US$ in 2017 and will reach 2950 million US$ by the end of 2025, growing at a CAGR of 7.5% during 2018-2025.
The major manufacturers covered in this report
Mylan
BD
Johnson & Johnson
Amgen Inc.
Eli Lilly
Biogen Idec
Bayer
Meridian (Pfizer)
Ypsomed Holding
Kaleo, Inc.
Owen Mumford
Antares Pharma, Inc.
Medeca Pharma AB
Request Sample Report at https://www.wiseguyreports.com/sample-request/3219930-global-auto-injectors-market-research-report-2018
Geographically, this report studies the key regions, focuses on product sales, value, market share and growth opportunity in these regions, covering
North America
Europe
China
Japan
Southeast Asia
India
We can also provide the customized separate regional or country-level reports, for the following regions:
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Rest of Asia-Pacific
Europe
Germany
France
UK
Italy
Spain
Russia
Rest of Europe
Central & South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Saudi Arabia
Turkey
Rest of Middle East & Africa
On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
Disposable Auto-Injectors
Reusable Auto-Injectors
On the basis of the end users/applications, this report focuses on the status and outlook for major applications/end users, consumption (sales), market share and growth rate for each application, including
Anaphylaxis
Multiple Sclerosis
Rheumatoid Arthritis
Others
The study objectives of this report are:
To analyze and study the global Auto-Injectors sales, value, status (2013-2017) and forecast (2018-2025).
Focuses on the key Auto-Injectors manufacturers, to study the sales, value, market share and development plans in future.
Focuses on the global key manufacturers, to define, describe and analyze the market competition landscape, SWOT analysis.
To define, describe and forecast the market by type, application and region.
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends and factors driving or inhibiting the market growth.
To analyze the opportunities in the market for stakeholders by identifying the high growth segments.
To strategically analyze each submarket with respect to individual growth trend and their contribution to the market
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market
To strategically profile the key players and comprehensively analyze their growth strategies.
In this study, the years considered to estimate the market size of Auto-Injectors are as follows:
History Year: 2013-2017
Base Year: 2017
Estimated Year: 2018
Forecast Year 2018 to 2025
For the data information by region, company, type and application, 2017 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Key Stakeholders
Auto-Injectors Manufacturers
Auto-Injectors Distributors/Traders/Wholesalers
Auto-Injectors Subcomponent Manufacturers
Industry Association
Downstream Vendors
About Us:
Wise Guy Reports is part of the Wise Guy Research Consultants Pvt. Ltd. and offers premium progressive statistical surveying, market research reports, analysis & forecast data for industries and governments around the globe.
Contact Us:
NORAH TRENT
Ph: +1-646-845-9349 (US)
Ph: +44 208 133 9349 (UK)